Institutes, Divisions & Centers
Experimental Hematology and Cancer Biology

Experimental Hematology and Cancer Biology Research

The Division of Experimental Hematology and Cancer Biology is committed to hematology, cancer and gene therapy research and strives to understand the biology of blood cell formation and function and to dissect cancer etiology and pathology. Our findings can be used in the development of innovative treatments of genetic and acquired diseases affecting the blood system and cancer.

The Division of Experimental Hematology and Cancer Biology has a close and specialized relationship with the Cancer and Blood Diseases Institute, enhancing two-way translational research and leading to more innovation in both clinical trials and delivery of care. The partnership also serves to enhance institutional utilization of gene therapy modalities in the treatment of devastating pediatric diseases.

Related Resources

The Division of Experimental Hematology and Cancer Biology is part of the Cancer and Blood Diseases Institute. The institute also includes the Divisions of Bone Marrow Transplantation and Immune Deficiency, Hematology and Oncology.

Research Faculty

Our team includes talented research faculty, research assistants, graduate assistants, postdoctoral fellows and support staff working in a number of developing programs and faculty labs. The Division is directed by Yi Zheng, PhD.

Research Achievements

Research Annual Report cover with a graphic of a microscope.

Learn more about our most significant findings and view grant funding and division statistics in this year's Research Annual Report.

Learn More
Cancer.

#1 in the Nation

Our cancer program is ranked #1 in the nation in the list of Best Children’s Hospitals published by U.S. News & World Report.

Learn More